Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02827838Early Phase 1Terminated
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
PrincipalinvestigatorStart date: 2017-01-01
NCT02582008Early Phase 1Terminated
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Current SmokerHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+4 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Charalampos Floudas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNasopharyngeal CarcinomaOral Squamous Cell Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNasopharyngeal Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Ye Guo, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Nasopharyngeal CarcinomaSquamous Cell Carcinoma of Head and Neck
Similarity Score3%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score2%

Novartis Vaccines and Diagnostics

Novartis

Related
12 trials

Shared therapeutic areas:

Human Papillomavirus Infection
Similarity Score2%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Vikrant Sahasrabuddhe, MBBS, MPH, DrPH

Division of Cancer Prevention (DCP), NCI

Related
2 trials

Shared therapeutic areas:

Human Papillomavirus Infection

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score2%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Gaetano Isola

University of Catania

Related
12 trials

Shared therapeutic areas:

Human Papillomavirus Infection
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02827838Early Phase 1PrincipalInvestigator

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Terminated
NCT02582008Early Phase 1PrincipalInvestigator

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Current SmokerHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+4 more
Terminated

All 2 trials loaded